{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:57:31Z","timestamp":1787003851490,"version":"build-2736575974"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2003,8,1]],"date-time":"2003-08-01T00:00:00Z","timestamp":1059696000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2003,8]]},"DOI":"10.1038\/sj.bjc.6601158","type":"journal-article","created":{"date-parts":[[2003,8,12]],"date-time":"2003-08-12T14:10:57Z","timestamp":1060697457000},"page":"625-629","source":"Crossref","is-referenced-by-count":85,"title":["Therapeutic efficiency of rhenium-188-HEDP in human prostate cancer skeletal metastases"],"prefix":"10.1038","volume":"89","author":[{"given":"K","family":"Liepe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Kropp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Runge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Kotzerke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2003,8,12]]},"reference":[{"key":"BF6601158_CR1","unstructured":"American Cancer Society (1991) Cancer Facts and Figures \u2013 1991, P. 5 Atlanta, GA: ACS"},{"key":"BF6601158_CR2","first-page":"725","volume":"36","author":"HL Atkins","year":"1995","unstructured":"Atkins HL, Mausner LF, Srivastava SC, Meiken GE, Cabahug CJ, D'Alessandro T (1995) Tin-117m(+4)-DTPA for palliation of pain from osseous metastases: a pilot study. J Nucl Med 36: 725\u2013729","journal-title":"J Nucl Med"},{"key":"BF6601158_CR3","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/BF00254749","volume":"12","author":"GM Blake","year":"1986","unstructured":"Blake GM, Zivanovic MA, McEwan AJ, Ackery DM (1986) Sr-89 therapy: strontium kinetics in disseminated carcinoma of the prostate. Eur J Nucl Med 12: 447\u2013454","journal-title":"Eur J Nucl Med"},{"key":"BF6601158_CR4","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1007\/s002590000307","volume":"27","author":"PJ Blower","year":"2000","unstructured":"Blower PJ, Kettle AG, O'Doherty MJ, Coakley AJ, Knapp Jr FF (2000) 99mTc(V)DMSA quantitatively predicts 188Re(V)DMSA distribution in patients with prostate cancer metastatic to bone. Eur J Nucl Med 27: 1405\u20131409","journal-title":"Eur J Nucl Med"},{"issue":"Suppl","key":"BF6601158_CR5","first-page":"265","volume":"5","author":"SL Chen","year":"2000","unstructured":"Chen SL (2000) Treatment of metastatic bone pain with 188Re-HEDP. J Nucl Med 5 (Suppl): 265","journal-title":"J Nucl Med"},{"key":"BF6601158_CR6","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1007\/s002590100533","volume":"28","author":"A Dafermou","year":"2001","unstructured":"Dafermou A, Colamussi P, Giganti M, Cittani C, Bestagno M, Piffanelli A (2001) A multicentre observation study of radionuclide therapy in patients with painful bone metastases of prostate cancer. Eur J Nucl Med 28: 788\u2013798","journal-title":"Eur J Nucl Med"},{"key":"BF6601158_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-3835(02)00413-5","volume":"187","author":"JD Debes","year":"2002","unstructured":"Debes JD, Tindall DJ (2002) The role of androgens and the androgen receptor in prostate cancer. Cancer Lett 187: 1\u20137","journal-title":"Cancer Lett"},{"key":"BF6601158_CR8","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/0883-2889(86)90269-8","volume":"37","author":"M Eisenhut","year":"1986","unstructured":"Eisenhut M, Fritz P, Kimmig B, Wingen F, Krempen B (1986) Iodine-131-labeled diphosphonate for the palliative treatment of bone metastases. Appl Radiat Isot 37: 741\u2013747","journal-title":"Appl Radiat Isot"},{"key":"BF6601158_CR9","first-page":"29","volume":"1","author":"O Enrique","year":"2002","unstructured":"Enrique O, Zhonyun P, Prma EP, Pusuwan P, Riccabona G, Tian J-H, Obaldo J, Padhy AK (2002) Efficacy and toxicity of Sm-153 EDTMP in the palliative treatment of painful bone metastases. World J Nucl Med 1: 29\u201334","journal-title":"World J Nucl Med"},{"key":"BF6601158_CR10","first-page":"559","volume":"64","author":"HL Friedell","year":"1950","unstructured":"Friedell HL, Storaassli JP (1950) The use of radioactive phosphorus in the treatment of carcinoma of the breast with widespread metastasis in bone. AJR 64: 559\u2013575","journal-title":"AJR"},{"key":"BF6601158_CR11","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0090-4295(02)01583-2","volume":"60","author":"T Gilligan","year":"2002","unstructured":"Gilligan T, Kantoff PW (2002) Chemotherapy for prostate cancer. Urology 60: 94\u2013100","journal-title":"Urology"},{"key":"BF6601158_CR12","first-page":"1271","volume":"41","author":"S Guhlke","year":"2000","unstructured":"Guhlke S, Beets AL, Oetjen K, Mirzadeh S, Biersack HJ, Knapp FF (2000) Simple new method for effective concentration of 188Re solutions from alumina-based 188W-188Re-generator. J Nucl Med 41: 1271\u20131278","journal-title":"J Nucl Med"},{"key":"BF6601158_CR13","first-page":"1783","volume":"17","author":"FF Knapp Jr","year":"1997","unstructured":"Knapp Jr FF, Beets AL, Guhlke S, Zamora PO, Bender H, Palmedo A, Biersack HJ (1997) Development of the alumina-based tungsten-188\/rhenium-188 generator and use of rhenium-188-labeled radiopharmaceutical for cancer treatment. Anticancer Res 17: 1783\u20131796","journal-title":"Anticancer Res"},{"key":"BF6601158_CR14","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1007\/s002590000315","volume":"27","author":"F Kraeber-Bodere","year":"2000","unstructured":"Kraeber-Bodere F, Campion L, Rousseau C, Bourdin S, Chatal JF, Resche I (2000) Treatment of bone metastases of prostate cancer with strontium-89 chloride: efficacy in relation to the degree of bone involvement. Eur J Nucl Med 27: 1487\u20131493","journal-title":"Eur J Nucl Med"},{"key":"BF6601158_CR15","unstructured":"Krebsregister in Deutschland (1999) Cancer in Germany. Robert Koch Institute. Saarbr\u00fccken, Germany"},{"key":"BF6601158_CR16","first-page":"171","volume-title":"Radionuclides for Prostatic Gland","author":"J Kutzner","year":"1991","unstructured":"Kutzner J, Hahn K, Grimm W, Brod K, R\u00f6sler HP (1991) Treatment of bone metastases of the prostate with yttrium isotope. In Radionuclides for Prostatic Gland, Limouris G, Shukla SK (eds.) pp 171\u2013183. Rome"},{"key":"BF6601158_CR17","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/BF02261248","volume":"20","author":"VJ Lewington","year":"1993","unstructured":"Lewington VJ (1993) Targeted radionuclide therapy for bone metastases. Eur J Nucl Med 20: 66\u201374","journal-title":"Eur J Nucl Med"},{"key":"BF6601158_CR18","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1097\/00003072-200111000-00006","volume":"26","author":"S Li","year":"2001","unstructured":"Li S, Liu J, Zhang H, Tian M, Wang J, Zheng X (2001) Rhenium-188 HEDP to treat painful bone metastases. Clin Nucl Med 26: 919\u2013922","journal-title":"Clin Nucl Med"},{"key":"BF6601158_CR19","first-page":"590","volume":"24","author":"W Lin","year":"1997","unstructured":"Lin W, Lin C, Yeh S, Hsieh B, Tsai Z, Ting G, Yen T, Wang S, Knapp FF, Stabin M (1997) Rhenium-188 HEDP: a new generator-produced radio-therapeutic drug of potential value for treatment of bone metastases. Eur J Nucl Med 24: 590\u2013595","journal-title":"Eur J Nucl Med"},{"key":"BF6601158_CR20","first-page":"953","volume":"44","author":"K Liepe","year":"2003","unstructured":"Liepe K, Hliscs R, Kropp J, Runge R, Knapp Jr FF, Franke WG (2003) Dosimetry of 188Re-hydroxyethylidene diphosphonate in human prostate cancer skeletal metastases. J Nucl Med 44: 953\u2013960","journal-title":"J Nucl Med"},{"key":"BF6601158_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00003072-200011000-00009","volume":"25","author":"K Liepe","year":"2000","unstructured":"Liepe K, Kropp J, Hliscs R, Franke WG (2000) Significant reduction of the mass of bone metastasis 1 year after rhenium-186 HEDP pain palliation therapy. Clin Nucl Med 25: 1\u20134","journal-title":"Clin Nucl Med"},{"key":"BF6601158_CR22","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1148\/radiology.176.1.1693784","volume":"176","author":"HR Maxon","year":"1990","unstructured":"Maxon HR, Schroder L, Thomas SR (1990) Re-186(Sn)HEDP for treatment of painful osseous metastases: initial clinical experience in 20 patients with hormone-resistant prostate cancer. Radiology 176: 155\u2013159","journal-title":"Radiology"},{"issue":"4","key":"BF6601158_CR23","first-page":"659","volume":"39","author":"HR Maxon","year":"1998","unstructured":"Maxon HR, Schroder LE, Washburn LC, Thomas SR, Samaratunga RC, Biniakiewicz D, Moulton JS, Cummings D, Ehrhardt GJ, Morris V (1998) Rhenium-188(Sn)HEDP for treatment of osseous metastases. J Nucl Med 39 (4): 659\u2013663","journal-title":"J Nucl Med"},{"key":"BF6601158_CR24","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1089\/cbr.1998.13.413","volume":"13","author":"AJ McEwan","year":"1998","unstructured":"McEwan AJ (1998) Palliative therapy with bone seeking radiopharmaceuticals. Cancer Biother Radiopharm 13: 413\u2013426","journal-title":"Cancer Biother Radiopharm"},{"key":"BF6601158_CR25","first-page":"1437","volume":"33","author":"WC Mertens","year":"1992","unstructured":"Mertens WC, Porter AT, Reid RH, Powe JE (1992) Strontium-89 and low dose infusion cisplatin for patients with hormone refractory prostate carcinoma metastatic to bone: a preliminary report. J Nucl Med 33: 1437\u20131443","journal-title":"J Nucl Med"},{"key":"BF6601158_CR26","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1200\/JCO.1991.9.3.509","volume":"9","author":"OS Nielsen","year":"1991","unstructured":"Nielsen OS, Munro AJ, Tannock IF (1991) Bone metastases: pathophysiology and management policy. J Clin Oncol 9: 509\u2013524","journal-title":"J Clin Oncol"},{"key":"BF6601158_CR27","unstructured":"Office for National Statistics Series DH. No 23 (1996) Mortalitiy Statistics by Cause: England and Wales 1996. London, UK: Her Majesty's Stationary Office"},{"issue":"2","key":"BF6601158_CR28","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s002590050017","volume":"27","author":"H Palmedo","year":"2000","unstructured":"Palmedo H, Guhlke S, Bender H, Sartor J, Schoeneich G, Risse J, Grunwald F, Knapp Jr FF, Biersack HJ (2000) Dose escalation study with rhenium-188 hydroxyethylidene diphosphonate in prostate cancer patients with osseous metastases. Eur J Nucl Med 27 (2): 123\u2013130","journal-title":"Eur J Nucl Med"},{"key":"BF6601158_CR29","first-page":"117","volume":"2","author":"P Pecher","year":"1942","unstructured":"Pecher P (1942) Biological investigation with radioactive calcium and strontium. Preliminary report on the use of radioactive strontium in the treatment of metastatic bone cancer. Univ Calif Publ Pharmacology 2: 117\u2013149","journal-title":"Univ Calif Publ Pharmacology"},{"key":"BF6601158_CR30","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1148\/radiographics.9.2.2467331","volume":"9","author":"G Robinson","year":"1989","unstructured":"Robinson G, Blake G, Preston DF, McEwan A, Spicer J, Martin N, Wegst A, Ackery D (1989) Strontium-89: treatment results and kinetics in patients with painful metastatic prostate and breast cancer in bone. Radiographics 9: 271\u2013281","journal-title":"Radiographics"},{"key":"BF6601158_CR31","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1200\/JCO.1998.16.4.1574","volume":"16","author":"AN Serafini","year":"1998","unstructured":"Serafini AN, Houston SJ, Resche I, Quick DP, Grund FM, Ell PJ, Bertrand A, Ahrnmann FR, Orihuela E, Reid RH, Lerski RA, Collier BD, Mckillop JH, Purnell GL, Pecking AP, Thomas FD, Harrison KA (1998) Palliation of pain associated with metastatic bone cancer using samarium-153 lexidronam: a double-blind placebo-controlled clinical trial. J Clin Oncol 16: 1574\u20131581","journal-title":"J Clin Oncol"},{"key":"BF6601158_CR32","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1200\/JCO.1989.7.12.1926","volume":"7","author":"JH Turner","year":"1989","unstructured":"Turner JH, Claringbold PG, Hetherington EL, Sorby P, Martindale AA (1989) A phase I study of samarium-153 ethylenediaminetetramethylene phosphonate therapy for disseminated skeletal metastases. J Clin Oncol 7: 1926\u20131931","journal-title":"J Clin Oncol"},{"key":"BF6601158_CR33","unstructured":"World Health Organization (1979) WHO Handbook for Reporting Results of Cancer Treatment. Geneve, Switzerland: World Health Organization, Offset publication 48"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6601158.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6601158","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6601158.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T08:51:46Z","timestamp":1684399906000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6601158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,8]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2003,8]]}},"alternative-id":["BF6601158"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6601158","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,8]]}}}